Menu

David Kim’s practice focuses on public and private securities offerings. He represents high-growth companies and investment banks in a variety of equity and debt transactions, including initial public offerings, other equity offerings, and high-yield, investment-grade and convertible debt offerings.

Download full bio 

Experience

  • PROCEPT BioRobotics – $188.5 Million IPO 

  • Erasca – $345 Million IPO 

  • Ventyx Biosciences – $174.3 Million IPO 

Education

  • Georgetown University Law Center
    JD, 2017

  • New York University
    BS, Media, Culture & Communication
    magna cum laude, 2014


Admissions & Credentials

California

New York